Deni Szokoli
szokoli.bsky.social
Deni Szokoli
@szokoli.bsky.social
Studying ancient ribozymes. Likes group II introns a little too much. PhD @mutschlerlab.bsky.social
loci encoding lncRNA aren't genes? How would you define a gene? Notoriously tricky problem.
November 28, 2025 at 3:36 PM
Employing "a much larger ribozyme" is always the solution to any problem, in my opinion.
July 3, 2025 at 7:49 PM
Thank you so much for sharing! I'm glad you like it!
July 3, 2025 at 10:58 AM
Thank you! Yes, absolutely! We wouldn't know what to do without it. I strongly recommend people check it out! www.rnacanvas.app
RNAcanvas
A web app for drawing and exploring nucleic acid structures.
www.rnacanvas.app
July 2, 2025 at 6:58 PM
Yes, that's correct, and honestly I was surprised with how well it worked, too. I believe the trick was paying close attention to sequence/structure motif conservation which seems to hold sufficient information to reconstruct the whole ribozyme class.
July 2, 2025 at 3:26 PM
I'm grateful to my student Lukas, who did a lot of the early characterization of Arq.I2, and of course @mutschlerlab.bsky.social for his mentorship and making this project possible! And ofc @crc392molevo.bsky.social!

I will be answering any questions, so feel free to ask if you have any! (11/11)
July 2, 2025 at 10:01 AM
This project was my brainchild and I'm overjoyed to finally see it published!

I want to thank my co-1st author: @noemi-n.bsky.social for all her hard work in seeing the project through until the end! I expect a lot of cool upcoming work from her, so follow her if you like group II introns! (10/11)
July 2, 2025 at 10:01 AM
This work serves as a proof of concept for the viability of complex ncRNA design through inverse folding, and we hope it paves the way for the computational design of bespoke G2Is and possibly other complex ncRNAs with traits that are favorable for biotech or therapeutic applications. (9/11)
July 2, 2025 at 10:01 AM
Surprisingly, we saw modest GFP expression compared to a control with an inactive intron. G2Is tend to silence host genes by cleaving the mRNA, so lowered expression is not unexpected. These results indicate that the protein-free intron is active in E. coli cells. (8/n)
July 2, 2025 at 10:01 AM
According to conventional wisdom, G2Is require protein cofactors to aid in self-splicing under intracellular conditions, hindering their application as protein-free genome editors.

We designed an assay for splicing-dependent fluorescent protein expression — a GFP gene interrupted by Arq.I2 (7/n)
July 2, 2025 at 10:01 AM
Unlike typical de novo designed ribozymes, Arq.I2 outperforms most wild type variants characterized thus far! It reacts with fast kinetics, having a rate of splicing comparable to those of the fastest known natural G2Is! (6/n)
July 2, 2025 at 10:01 AM
All three candidates were active in vitro, some even outperforming a variant of a natural intron.
Arq.I2 is a very unusual intron — it requires extreme measures to denature it for PAGE, and remains catalytically active in the absence of monovalent cations. (5/n)
July 2, 2025 at 10:01 AM
In our latest paper we combined the inverse folding algorithm aRNAque and rational design to generate unique synthetic G2Is.
aRNAque's evolutionary algorithm was able to finetune intron folding, resulting in unusually stable structures. (4/n)
July 2, 2025 at 10:01 AM
Protein-free G2Is were recently found to hydrolyze dsDNA, showing potential as RNA-only genome editors (see my previous thread). However, their complexity poses a challenge to their de novo design, as only short ribozymes have ever been generated using inverse folding algorithms. (3/n)
July 2, 2025 at 10:01 AM
G2Is are self-splicing retroelements found in all domains of life, and are the ancestors of the spliceosome.
Owing to dozens of tertiary interactions and a large conformational change between the steps of catalysis, they are among the largest and most complex ribozymes. (2/n)
July 2, 2025 at 10:01 AM